NNMT in Cardiovascular Disease 5-Amino-1MQ as a Research Tool (MDPI, 2025) NNMT Inhibition as a Strategy for Cardiovascular Metabolic Pathway Research A 2025 review published in Biomolecules (MDPI) examined NNMT as a metabolic regulator in cardiovascular disease pathogenesis and identified 5-Amino-1MQ as a key research tool for investigating NNMT-mediated cardiovascular metabolic pathways
Current clinical trials and preclinical studies provide a foundation for understanding the role of NAD+ in health and disease, but further investigation is required to determine optimal dosing, long-term effects, and potential risks
(Reference 1) Gut Health: Research shows it may support gastrointestinal integrity
Convenient Pack of 2: Contains 2 bottles with 30 tablets each, formulated with premium ingredients for easy daily consumption
Jennings LA, Laffan AM, Schlissel AC, et al
Metabolic Dysfunction in Alzheimer's Disease and Related Neurodegenerative Disorders